🇺🇸 FDA
Patent

US 11661611

Genetic modification of cytokine inducible SH2-containing protein (CISH) gene

granted A61KA61K48/00

Quick answer

US patent 11661611 (Genetic modification of cytokine inducible SH2-containing protein (CISH) gene) held by Sangamo Therapeutics, Inc. expires Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Therapeutics, Inc.
Grant date
Tue May 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K48/00